Dataset opportunity
Lacollectemedicale — 监管记录数据集机会
Lacollectemedicale 持有的中等监管记录数据集,可用于监管 RAG 和合规性 Copilots。
Score
58.7
Score (0–100) blends weighted dimensions — dataset rarity, training value, buyer demand, evidence strength and right-to-license. 70+ is deal-ready. See the scored dimensions below for the breakdown.Confidence
42%
Action
数据共享协议
The recommended deal structure for this dataset: Acquire (full buyout), License (paid usage rights), Data Sharing Agreement (controlled access, no transfer of ownership), Partnership (co-development) or Annotation Program (labeling). Chosen from data ownership, licensing complexity and accessibility.Market size (indicative estimate)
全球医疗废物管理市场在 2024 年的估值为 101.8 亿美元,预计到 2032 年将达到 162.8 亿美元,复合年增长率为 6.05%。
Recent dated external facts that triggered this opportunity — auditable provenance.
- 📰press2026-11-06
La Collecte Médicale planifie ses tournées PTV OptiFlow
supplychainmagazine.fr ↗
Lineage
How this lead was derived
The signal-first chain, end to end: recent external signals → qualified niche → resolved data-holder → site verification → scored opportunity. Every lead is explainable.
Concrete evidence this company actively cares about data — why it's ripe for the deal room.
Profile
Dataset profile
Type
监管记录数据集
Modality
文本
Sector
医疗保健
Volume
中等
Freshness
定期
Rarity
中等
Accessibility
受限
Legal
公司所有 — GDPR 敏感(PII 审查)
Buyer persona
RegTech 和合规性 AI 供应商
Lacollectemedicale 持有文本模态的监管记录数据集,其中包含法国传染性医疗废物在法律上强制要求的可追溯性记录。这些结构化数据涵盖了业务记录和监管证明,是训练和 grounding 监管 RAG 系统以应对废物管理合规性特定复杂性的理想来源。
该数据属于全球医疗废物管理市场,该市场在 2024 年的估值为 101.8 亿美元,预计将以 6.05% 的复合年增长率增长。尽管由于严格的法国 DASRI 法规以及专业 PII 的存在,访问存在复杂性,但该数据集的稀有性及其在人工智能驱动的合规自动化方面的直接适用性,使其对于寻求在此不断增长的市场中获得竞争优势的买家来说极具价值。⚠ 尽职调查(有价值的数据,可协商访问):数据受严格的法国 DASRI(传染性废物)法规约束;数据集包含专业 PII 和医疗保健设施的精确位置;可追溯性记录必须依法保存 3 年 · 公司:独立。
Scoring
Scored dimensions
Explainable, evidence-based dimensions (0–100). The radar shows the investment axes.
这些证据共同证明 Lacollectemedicale 拥有关于法国医疗废物管理的独特监管记录语料库。该数据集包含官方的废物类型监管定义以及相应的业务记录,例如记录合规性的焚烧清单。对于 RegTech 和合规性 AI 供应商而言,这些数据是开发监管 RAG 系统的关键资产,这些系统可以自动化和验证对复杂规则的遵守情况。在全球医疗废物市场预计到 2032 年将达到162.8 亿美元的情况下,该数据集提供了导航和货币化合规性挑战所需的地面真相文档。
See dimension details ↓- Dataset Specificity66
主导的‘监管’,医疗保健行业,1 种特定类型
How sharply the data targets a specific, hard-to-substitute domain or task. Niche, well-defined data scores higher than generic. - Dataset Rarity58
专有领域数据
How scarce and proprietary the data is. Unique domain data scores high; openly available data lowers it. - Dataset Volume46
2 个证据命中
Apparent scale of the data, inferred from the number of evidence hits and any explicit volume mentions. - Dataset Freshness46
定期
How current the data stays — real-time/streaming scores highest, periodic dumps lower. - Training Value64
适用于监管 RAG
How useful the data is for the target AI use-case — its fit for model training or fine-tuning. - Buyer Demand80
AI 买家对能够自动化合规性的解决方案需求强劲,因为不断增长的 101.8 亿美元医疗废物管理市场(6.05% 的复合年增长率)中,监管合规是主要的成本和风险驱动因素。
How strongly AI builders and companies are likely to want this data, based on market signals. - Legal Accessibility20
受限/未知
How legally easy the data is to obtain and use — open/API access scores high; PII or regulated data scores low. - Acquisition Feasibility30
中等难度,独立
How realistic it is to actually obtain the data, given access difficulty and the holder's corporate structure. - Evidence Strength50
2 种证据类型,2 次命中
How solid the proof is that the company holds this data — diversity of evidence types and number of hits. - Right to License62
所有权=公司所有,许可=GDPR 敏感
Whether the company can legally license the data out — based on ownership and licensing complexity. - Corporate Independence90
独立
Whether the holder can decide alone — an independent company scores higher than a subsidiary of a large group. - Data Orientation56
2 个数据胃口信号(2 种类型)
How actively the company invests in data, measured by its data-appetite signals (hires, products, APIs…). - Dormant Data Surplus70
盈余=中等,1 个近期外部信号 — 专有数据超出已货币化的范围
Volume and value of proprietary data this company holds BEYOND what it already monetises — the dormant surplus we can unlock. A company can sell some insights AND still sit on a far larger dormant asset. - ICP Audit92
✓ 良好目标 — 这家法国家庭拥有的医疗废物收集领导者是一个主要目标,因为它拥有大规模的实体运营,作为副产品产生专有的物流和废物数据,其核心业务是收集服务,而不是销售数据或情报。
- Deep Qualification80
⚠ 需要审查 — 目标是一家提供医疗废物管理服务的**数据持有者**;它不销售数据。它生成的监管可追溯性记录由其客户(废物生产者)合法拥有,因此直接获取数据的可能性不大。但是,数据的存在和监管性质已得到确认。[数据归公司客户所有]
Evidence
Dataset evidence & lineage
What the typed evidence proves the company holds — reframed for clarity and set against the market.
business_records
这些证据证实了结构化业务记录的存在,特别是根据法规存档的废物收集和焚烧清单,为以合规为中心的 AI 应用提供了可验证的审计跟踪。
Regulatory records
这段文字是官方的监管定义,规定了人类和兽医来源的医疗废物的范围,这对于训练 AI 模型以根据法律标准正确分类和处理敏感材料至关重要。
Marketplace
Dataset details
Detailed schema & sample available on access request.
Want this data?
Request access — we broker a secure deal room. Operator-reviewed, no automatic sharing.
This listing was generated automatically from public signals. It is not verified, and we are not affiliated with this company.
Coverage
Scanned sources
Deliverable
Premium dataset report
Lacollectemedicale Regulatory Records — a Moderate regulatory records dataset (Text modality) in the healthcare domain. Primary AI use-case: Regulatory RAG. Market signal: Global Medical Waste Management market was valued at USD 10.18 billion in 2024, projected to reach USD 16.28 billion by 2032, at a 6.05% CAGR (source: Data Bridge Market Research).. Investment score 58.7/100 (confidence 0.42). Recommended action: Data Sharing Agreement.
From the marketplace
Explore live data opportunities
Unsworth — 监管记录数据集机会
View opportunity →出行Deringer — 监管记录数据集机会
View opportunity →医疗保健Alivecor — API可访问数据集机会
View opportunity →